Existing drugs offer new treatment options for high-risk childhood leukemia subtype
MEMPHIS, Tenn., Aug. 13, 2012 /PRNewswire-USNewswire/ — Scientists have identified new genetic alterations underlying a high-risk subtype of the most common childhood cancer that could be effectively targeted with existing leukemia therapies.